Sankala Group’s Elanco Animal Health ELAN Stock Holding History

Sankala Group’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-150	Closed	-$3.96K	–	562
2025 Q4	$3.96K	Buy	+150	New	+$3.26K	﹤0.01%	464

Other funds holding ELAN

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Sankala Group's ELAN Position: Q1 2026 in Review

Sankala Group sold out of Elanco Animal Health (ELAN) in Q1 2026, closing a stake of 150 shares — an estimated $3.96K sold.

Sankala Group first reported a position in ELAN in Q4 2025 and held it in 1 quarter. The position peaked at $3.96K in Q4 2025. 516 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

Sankala Group reported no remaining Elanco Animal Health position as of Q1 2026 after selling out during the quarter.
Sankala Group sold 150 Elanco Animal Health shares in Q1 2026, an estimated $3.96K.
Sankala Group first reported a position in Elanco Animal Health in Q4 2025 and held it in 1 quarter.
Sankala Group's Elanco Animal Health position peaked at $3.96K in Q4 2025.
516 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Sankala Group's 13F filing for Q1 2026, filed 31 Mar 2026.